Posaconazol Devatis 100 mg
Posaconazol Devatis 100 mg is a medicine authorised by Swissmedic under authorisation number 69323. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 May 2024 and the authorisation is limited until 07 May 2029. ATC code J02AC04 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 69323 |
|---|---|
| Name | Posaconazol Devatis 100 mg |
| Full name | Posaconazol Devatis 100 mg, magensaftresistente Tablette |
| Authorisation holder | Devatis AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | J02AC04 |
| First authorisation | 08 May 2024 |
| Authorisation validity | 07 May 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Posaconazol Devatis 100 mg, magensaftresistente Tablette | B | 08 May 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 24 | Tablette(n) | J02AC04 | 08.06.0. | B |
| 2 | 96 | Tablette(n) | J02AC04 | 08.06.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Posaconazol Devatis 100 mg authorised in Switzerland?
Yes. Posaconazol Devatis 100 mg is authorised by Swissmedic under authorisation number 69323, data as of 01 September 2026. The authorisation is limited until 07 May 2029.
Which dispensing category does Posaconazol Devatis 100 mg have?
Posaconazol Devatis 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Posaconazol Devatis 100 mg?
The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.